Sponsor or institution
Clinical trials and research at Sitala Bio LTD
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Sitala Bio LTD that are recruiting, at sites in 7 countries (most in Australia (2), Argentina (1), Czechia (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 7Countries
All recruiting trials (2)
-
See if STL303 helps adults with geographic atrophy from AMD
This study tests STL303 versus placebo in people 60 and older who have geographic atrophy due to age-related macular degeneration to see if it is safe and can help their vision.
-
Safety and helpful dose test of STL303 in adults with IgA nephropathy
A small, multi-center study will test different doses of STL303 or placebo to see if it helps adults with primary IgA nephropathy.
Quick answers
How many clinical trials run by Sitala Bio LTD are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Australia (2 trials), Argentina (1 trial), Czechia (1 trial), Poland (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.